148 related articles for article (PubMed ID: 37409717)
1. [Review of real-life teduglutide experience].
Campos Martín C; Tejera Pérez C; Virgili-Casas N; Irles-Rocamora JA
Nutr Hosp; 2023 Aug; 40(4):886-894. PubMed ID: 37409717
[TBL] [Abstract][Full Text] [Related]
2. Factors Associated With Response to Teduglutide in Patients With Short-Bowel Syndrome and Intestinal Failure.
Jeppesen PB; Gabe SM; Seidner DL; Lee HM; Olivier C
Gastroenterology; 2018 Mar; 154(4):874-885. PubMed ID: 29174926
[TBL] [Abstract][Full Text] [Related]
3. Quality of life in patients with short bowel syndrome treated with the new glucagon-like peptide-2 analogue teduglutide--analyses from a randomised, placebo-controlled study.
Jeppesen PB; Pertkiewicz M; Forbes A; Pironi L; Gabe SM; Joly F; Messing B; Loth S; Youssef NN; Heinze H; Berghöfer P
Clin Nutr; 2013 Oct; 32(5):713-21. PubMed ID: 23587733
[TBL] [Abstract][Full Text] [Related]
4. [Is there life after teduglutide?].
Martínez Martínez AL; Calles Romero LA; Etxeberría Martín E; Monasterio Jiménez O; Zabalegui Eguinoa A; Paja Fano M; Monzón Mendiolea A; Cadenas González A; Cabriada Nuno JL; Iglesias Hernández NC
Nutr Hosp; 2020 Jul; 34(3):631-635. PubMed ID: 32406744
[TBL] [Abstract][Full Text] [Related]
5. Impact of Teduglutide on Quality of Life Among Patients With Short Bowel Syndrome and Intestinal Failure.
Chen K; Mu F; Xie J; Kelkar SS; Olivier C; Signorovitch J; Jeppesen PB
JPEN J Parenter Enteral Nutr; 2020 Jan; 44(1):119-128. PubMed ID: 31006876
[TBL] [Abstract][Full Text] [Related]
6. Experience with teduglutide treatment for short bowel syndrome in clinical practice.
Pevny S; Maasberg S; Rieger A; Karber M; Blüthner E; Knappe-Drzikova B; Thurmann D; Büttner J; Weylandt KH; Wiedenmann B; Müller VA; Bläker H; Pascher A; Pape UF
Clin Nutr; 2019 Aug; 38(4):1745-1755. PubMed ID: 30145039
[TBL] [Abstract][Full Text] [Related]
7. Teduglutide (ALX-0600), a dipeptidyl peptidase IV resistant glucagon-like peptide 2 analogue, improves intestinal function in short bowel syndrome patients.
Jeppesen PB; Sanguinetti EL; Buchman A; Howard L; Scolapio JS; Ziegler TR; Gregory J; Tappenden KA; Holst J; Mortensen PB
Gut; 2005 Sep; 54(9):1224-31. PubMed ID: 16099790
[TBL] [Abstract][Full Text] [Related]
8. Six-month outcomes of teduglutide treatment in adult patients with short bowel syndrome with chronic intestinal failure: A real-world French observational cohort study.
Joly F; Seguy D; Nuzzo A; Chambrier C; Beau P; Poullenot F; Thibault R; Armengol Debeir L; Layec S; Boehm V; Lallemand J; Quilliot D; Schneider SM
Clin Nutr; 2020 Sep; 39(9):2856-2862. PubMed ID: 31932048
[TBL] [Abstract][Full Text] [Related]
9. Cost-effectiveness of teduglutide in adult patients with short bowel syndrome: Markov modeling using traditional cost-effectiveness criteria.
Raghu VK; Binion DG; Smith KJ
Am J Clin Nutr; 2020 Jan; 111(1):141-148. PubMed ID: 31665212
[TBL] [Abstract][Full Text] [Related]
10. The Polish Intestinal Failure Centres' consensus on the use of teduglutide for the treatment of short bowel syndrome.
Klek S; Kunecki M; Sobocki J; Matysiak K; Karwowska K; Urbanowicz K
Nutrition; 2017 Jun; 38():28-33. PubMed ID: 28526379
[TBL] [Abstract][Full Text] [Related]
11. Long-Term Therapy With Teduglutide in Parenteral Support-Dependent Patients With Short Bowel Syndrome: A Case Series.
Ukleja A; To C; Alvarez A; Lara LF
JPEN J Parenter Enteral Nutr; 2018 May; 42(4):821-825. PubMed ID: 29603279
[TBL] [Abstract][Full Text] [Related]
12. Colon polyps in patients with short bowel syndrome before and after teduglutide: Post hoc analysis of the STEPS study series.
Armstrong D; Forbes A; Jeppesen PB; Lee HM; Nagy P; Seidner DL
Clin Nutr; 2020 Jun; 39(6):1774-1777. PubMed ID: 31522784
[TBL] [Abstract][Full Text] [Related]
13. Single-Center Experience with the Use of Teduglutide in Adult Patients with Short Bowel Syndrome.
Lam K; Schwartz L; Batisti J; Iyer KR
JPEN J Parenter Enteral Nutr; 2018 Jan; 42(1):225-230. PubMed ID: 29505151
[TBL] [Abstract][Full Text] [Related]
14. Use of teduglutide in adults with short bowel syndrome-associated intestinal failure.
Pironi L; Allard JP; Joly F; Geransar P; Genestin E; Pape UF
Nutr Clin Pract; 2024 Feb; 39(1):141-153. PubMed ID: 37294295
[TBL] [Abstract][Full Text] [Related]
15. Teduglutide for the treatment of short bowel syndrome - a safety evaluation.
Kochar B; Herfarth HH
Expert Opin Drug Saf; 2018 Jul; 17(7):733-739. PubMed ID: 29848084
[TBL] [Abstract][Full Text] [Related]
16. Predictors and timing of response to teduglutide in patients with short bowel syndrome dependent on parenteral support.
Chen K; Joly F; Mu F; Kelkar SS; Olivier C; Xie J; Seidner DL
Clin Nutr ESPEN; 2021 Jun; 43():420-427. PubMed ID: 34024550
[TBL] [Abstract][Full Text] [Related]
17. Changes in Parenteral Nutrition Requirements and BMI in Patients with Parenteral Nutrition-Dependent Short Bowel Syndrome after Stopping Teduglutide-9 Years of Follow-Up.
Zaczek Z; Jurczak-Kobus P; Panczyk M; Braszczyńska-Sochacka J; Majewska K; Kunecki M; Dąbrowska K; Sobocki J
Nutrients; 2022 Apr; 14(8):. PubMed ID: 35458196
[TBL] [Abstract][Full Text] [Related]
18. Cost-effectiveness of teduglutide in adult patients with short bowel syndrome - a European socioeconomic perspective.
Walter E; Dawoud C; Hütterer E; Stift A; Harpain F
Am J Clin Nutr; 2024 May; 119(5):1187-1199. PubMed ID: 38431119
[TBL] [Abstract][Full Text] [Related]
19. Cost-utility analysis of teduglutide compared to standard care in weaning parenteral nutrition support in children with short bowel syndrome.
Gattini D; Belza C; Kraus R; Avitzur Y; Ungar WJ; Wales PW
Clin Nutr; 2023 Dec; 42(12):2363-2371. PubMed ID: 37862822
[TBL] [Abstract][Full Text] [Related]
20. Teduglutide in short bowel syndrome patients: A way back to normal life?
Harpain F; Schlager L; Hütterer E; Dawoud C; Kirchnawy S; Stift J; Krotka P; Stift A
JPEN J Parenter Enteral Nutr; 2022 Feb; 46(2):300-309. PubMed ID: 34614239
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]